Study of Celecoxib Bioavailability in Healthy Subjects

This study has been completed.

First Received: February 22, 2006 Last Updated: February 1, 2007 History of Changes

Sponsored by:	Pfizer
Information provided by:	Pfizer
ClinicalTrials.gov Identifier:	NCT00296127

Purpose

To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule

Condition	Intervention	Phase
Healthy Volunteers	Drug: Celecoxib	Phase I

Drug Information available for: Celecoxib

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Bio-availability Study
Official Title:	A Relative Bioavailability Study Of Celecoxib Administered As Capsule Contents Sprinkled On Applesauce In Healthy Adult Volunteers

Further study details as provided by Pfizer:

Primary Outcome Measures:

Relative bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative intact capsule after a single dose

Estimated Enrollment:	24
Study Start Date:	February 2006
Estimated Study Completion Date:	March 2006

Eligibility

Ages Eligible for Study:	18 Years to 55 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Healthy male and/or female subjects

Exclusion Criteria:

Standard criteria for healthy volunteer studies

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00296127

Locations

United States, Connecticut
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511-5473

Sponsors and Collaborators

Pfizer

Investigators

Study Director:

Pfizer CT.gov Call Center

Pfizer

More Information

Additional Information:

To obtain contact information for a study center near you, click here. This link exits the ClinicalTrials.gov site

Link to clinicalstudyresults.org results posting This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	A3191202
Study First Received:	February 22, 2006
Last Updated:	February 1, 2007
ClinicalTrials.gov Identifier:	NCT00296127 History of Changes
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Anti-Inflammatory Agents
Celecoxib
Analgesics, Non-Narcotic
Cyclooxygenase Inhibitors
Anti-Inflammatory Agents, Non-Steroidal

Peripheral Nervous System Agents
Analgesics
Healthy
Antirheumatic Agents

Additional relevant MeSH terms:

Anti-Inflammatory Agents
Celecoxib
Molecular Mechanisms of Pharmacological Action
Cyclooxygenase Inhibitors
Physiological Effects of Drugs
Enzyme Inhibitors
Pharmacologic Actions
Analgesics, Non-Narcotic

Sensory System Agents
Therapeutic Uses
Anti-Inflammatory Agents, Non-Steroidal
Analgesics
Peripheral Nervous System Agents
Antirheumatic Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on May 06, 2009